Characterization of human infiltrating and circulating gamma-delta T cells in prostate cancer

scientific article published on 26 February 2019

Characterization of human infiltrating and circulating gamma-delta T cells in prostate cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4111/ICU.2019.60.2.91
P932PMC publication ID6397928
P698PubMed publication ID30838341

P50authorAlchiede SimonatoQ57054853
Marco VellaQ59160465
Elena Lo PrestiQ86283211
P2093author name stringSerena Meraviglia
Cristina Scalici Gesolfo
Vincenzo Serretta
Alberto Abrate
Daniela Coniglio
P2860cites workBisphosphonates target multiple sites in both cis- and trans-prenyltransferasesQ27645000
Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gammaQ28386704
Thymic maturation determines gammadelta T cell function, but not their antigen specificitiesQ28389313
Antigen-Presenting Human γδ T Cells Promote Intestinal CD4+ T Cell Expression of IL-22 and Mucosal Release of CalprotectinQ33567987
Murine CD27(-) Vγ6(+) γδ T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophagesQ34119854
The influence of finasteride on the development of prostate cancerQ34534815
Prostate cancer lesions are surrounded by FOXP3+, PD-1+ and B7-H1+ lymphocyte clustersQ34605766
20-year outcomes following conservative management of clinically localized prostate cancerQ36115855
Differentiation of effector/memory Vdelta2 T cells and migratory routes in lymph nodes or inflammatory sitesQ36371370
Inflammation in prostate carcinogenesisQ36554784
Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancerQ36800215
The prognostic landscape of genes and infiltrating immune cells across human cancersQ36857285
Cutting edge: CD1d restriction and Th1/Th2/Th17 cytokine secretion by human Vδ3 T cells.Q37039445
Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytesQ37269077
Human prostate-infiltrating CD8+ T lymphocytes are oligoclonal and PD-1+.Q37435472
Questionable relevance of gamma delta T lymphocytes in renal cell carcinomaQ37473297
Current progress in γδ T-cell biology.Q37729208
Repertoire development and the control of cytotoxic/effector function in human gammadelta T cellsQ37731978
γδ T-APCs: a novel tool for immunotherapy?Q37875768
The emerging Protumor role of γδ T lymphocytes: implications for cancer immunotherapyQ38347451
IL-17A produced by γδ T cells promotes tumor growth in hepatocellular carcinoma.Q39024081
CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patientsQ40212457
Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study.Q40474302
Characterization of infiltrating lymphocytes in human benign and malignant prostate tissueQ41694140
Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewingQ41953761
Decreased Vδ2 γδ T cells associated with liver damage by regulation of Th17 response in patients with chronic hepatitis B.Q42284376
Gammadelta T cells for immune therapy of patients with lymphoid malignanciesQ44353687
Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo.Q44575984
A subset of IL-10-producing gammadelta T cells protect the liver from Listeria-elicited, CD8(+) T cell-mediated injury.Q52851254
P275copyright licenseCreative Commons Attribution-NonCommercial 4.0 InternationalQ34179348
P6216copyright statuscopyrightedQ50423863
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectbiopsyQ179991
urologyQ105650
P304page(s)91-98
P577publication date2019-02-26
P1433published inInvestigative and clinical urologyQ27727133
P1476titleCharacterization of human infiltrating and circulating gamma-delta T cells in prostate cancer
P478volume60

Reverse relations

Q97653023Cancer immunotherapy with γδ T cells: many paths ahead of uscites workP2860

Search more.